Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

SHE:300683 Statistics

Total Valuation

SHE:300683 has a market cap or net worth of CNY 4.28 billion. The enterprise value is 3.61 billion.

Market Cap	4.28B
Enterprise Value	3.61B

Important Dates

The next estimated earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

SHE:300683 has 130.89 million shares outstanding. The number of shares has decreased by -3.98% in one year.

Current Share Class	130.89M
Shares Outstanding	130.89M
Shares Change (YoY)	-3.98%
Shares Change (QoQ)	-2.82%
Owned by Insiders (%)	11.15%
Owned by Institutions (%)	0.87%
Float	73.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.91
PB Ratio	1.91
P/TBV Ratio	2.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-19.23
EV / Sales	5.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.36

Financial Position

The company has a current ratio of 4.60, with a Debt / Equity ratio of 0.00.

Current Ratio	4.60
Quick Ratio	4.11
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-105.62

Financial Efficiency

Return on equity (ROE) is -8.19% and return on invested capital (ROIC) is -8.64%.

Return on Equity (ROE)	-8.19%
Return on Assets (ROA)	-3.12%
Return on Invested Capital (ROIC)	-8.64%
Return on Capital Employed (ROCE)	-5.82%
Weighted Average Cost of Capital (WACC)	5.35%
Revenue Per Employee	473,554
Profits Per Employee	-143,390
Employee Count	1,309
Asset Turnover	0.22
Inventory Turnover	3.68

Taxes

Income Tax	-8.02M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.86% in the last 52 weeks. The beta is 0.20, so SHE:300683's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	+46.86%
50-Day Moving Average	29.66
200-Day Moving Average	33.09
Relative Strength Index (RSI)	58.63
Average Volume (20 Days)	9,519,220

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300683 had revenue of CNY 619.88 million and -187.70 million in losses. Loss per share was -1.45.

Revenue	619.88M
Gross Profit	240.48M
Operating Income	-139.13M
Pretax Income	-200.47M
Net Income	-187.70M
EBITDA	-38.61M
EBIT	-139.13M
Loss Per Share	-1.45

Balance Sheet

The company has 695.75 million in cash and 11.19 million in debt, with a net cash position of 684.56 million or 5.23 per share.

Cash & Cash Equivalents	695.75M
Total Debt	11.19M
Net Cash	684.56M
Net Cash Per Share	5.23
Equity (Book Value)	2.24B
Book Value Per Share	17.06
Working Capital	883.24M

Cash Flow

In the last 12 months, operating cash flow was -81.10 million and capital expenditures -61.20 million, giving a free cash flow of -142.29 million.

Operating Cash Flow	-81.10M
Capital Expenditures	-61.20M
Free Cash Flow	-142.29M
FCF Per Share	-1.09

Margins

Gross margin is 38.79%, with operating and profit margins of -22.44% and -30.28%.

Gross Margin	38.79%
Operating Margin	-22.44%
Pretax Margin	-32.34%
Profit Margin	-30.28%
EBITDA Margin	-6.23%
EBIT Margin	-22.44%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.43%.

Dividend Per Share	0.13
Dividend Yield	0.43%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.98%
Shareholder Yield	4.44%
Earnings Yield	-4.38%
FCF Yield	-3.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHE:300683 has an Altman Z-Score of 6.52 and a Piotroski F-Score of 3.

Altman Z-Score	6.52
Piotroski F-Score	3